Remibrutinib, is a potent and orally active bruton tyrosine kinase (BTK) inhibitor with an IC50 value of 1 nM. Remibrutinib inhibits BTK activity with an IC50 value of 0.023 µM in blood[1]. Remibrutinib has the potential for Chronic urticaria (CU) treatment[2].
Molecular Weight:
507.53
Purity:
99.76
CAS Number:
[1787294-07-8]
Formula:
C27H27F2N5O3
Target:
Btk
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted